The Amazon-owned grocer is lowering its prices
While the broader U.S. stock market struggles for direction, a number of individual stocks are making notable moves, including biopharmaceutical firm ADMA Biologics Inc (NASDAQ:ADMA), travel name Delta Air Lines, Inc. (NYSE:DAL), and supermarket chain Sprouts Farmers Market Inc (NASDAQ:SFM). Here's a quick look at what's moving the shares of ADMA, DAL, and SFM.
The shares of ADMA Biologics are near the top of the Nasdaq -- up 33.2% to trade at $5.42 -- after the U.S. Food and Drug Administration (FDA) approved the company's immune deficiency treatment, ASCENIV, with ADMA projecting a commercial launch in the second half of this year. Additionally, Oppenheimer boosted its price target to a Street-high $16, calling the approval a major milestone for ADMA.
The stock is pacing toward its best day ever, and options trading is accelerated. More specifically, 3,693 calls and 1,940 puts are on the tape -- 14 times the average intraday amount, and a new annual high. The April 7.50 call is most active, and it looks like new positions are being initiated here.
Delta Air Lines stock is headed toward a sixth straight win, up 7% at $55.82. Ahead of its earnings report, due before the open next Wednesday, April 10, the air carrier projected first-quarter adjusted profit above the consensus estimate, and said revenue passenger and average seat miles were both up in March. A price-target hike to $67 from $62 is only fanning the bullish flames.
There's room for more upbeat analyst notes, should the shares add to their 11.5% year-to-date gain. While four analysts still maintain a tepid "hold" recommendation, the average 12-month DAL price target of $62.95 is a tame 13.1% premium to current levels.
Sprouts Farmers Market shares are trading down 2.8% at $21.06, following news Amazon (AMZN) is cutting prices at Whole Foods. This negative price action is just part of a longer-term trend, with SFM stock off 28.9% from its Sept. 10 two-year high of $29.67.
Short sellers have been cashing out amid this slide. Short interest is down almost 20% from late December. However, bears are still firmly in control, considering the 12.9 million SFM shares sold short represents 10.8% of the stock's available float.